| NCT05320393 | Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines | COMPLETED | PHASE2 | 2022-03-30 | 2023-05-22 | 2023-05-22 |
| NCT02428608 | Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 | COMPLETED | PHASE2 | 2015-05 | 2016-11 | 2016-10 |
| NCT02334423 | A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001 | COMPLETED | PHASE3 | 2015-01 | 2015-12 | 2015-12 |
| NCT02334436 | A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 | COMPLETED | PHASE3 | 2015-01 | 2015-12 | 2015-09 |
| NCT02184988 | Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines | COMPLETED | PHASE2 | 2014-08 | 2015-12 | 2015-12 |